Abstract:Lung cancer is the leading cause of cancer death worldwide, and squamous carcinoma is the most common histological subtype. Clinical and molecular evidence indicated that lung squamous carcinoma is heterogeneous disease. Long non-coding RNAs (lncRNAs) were noncoding RNAs with more than 200 nucleotide length. They have been found to be involved in a variety of biological processes. Many studies indicated that they were aberrantly expressed in some types of carcinomas. In this study, we tested the hypothesis that some lncRNAs may correlate with lung cancer tumor genesis by detecting genome-scale lncRNAs expressions. 16 lung squamous cell carcinoma patients’paired normal and lung tumor tissues were obtained after surgery. First, extracted total RNA from frozen tissues by Trizol reagent; next, reverse-transcripted the total RNA to cDNA, got cRNA in vitro transcription synthesis, and then purified cRNA by spin columns, cRNA was transcribed into cDNA utilizing a random priming method and cDNA was labeled and hybridized to the Agilent human 4×180 K microarray. Processed signal data was obtained from hybridized images using Agilent Feature Extraction. Quantile normalization and differential expression data were performed using the Agilent GeneSpring. Data analyses were performed using R and Bioconductor. With abundant and varied probes accounting 38,361 lncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 28,055. From the results we found that there were 3,460 lncRNAs that differentially expressed (≥ 2 absolute fold-change) in lung squamous cell carcinoma tissues compared with normal tissue, among which 127 lncRNAs differentially expressed in all 16 lung squamous cell carcinoma samples. Our study is the first one to determine genome-wide lncRNAs expression patterns in lung squamous cell carcinoma by using microarray. The results indicated that clusters of lncRNAs were significantly differentially expressed. Of all 3,460 differentially expressed lncRNAs, 1901 lncRNAs were up-regulated and 1559 down-regulated. 9/16 lung squamous cell carcinoma patients’up-regulated lncRNAs were more common than down-regulated ones. 7/16 patients down-regulated lncRNAs were more common than up-regulated ones. To predict the functions of lncRNAs, we constructed coding–non-coding gene co-expression networks of lncRNAs and mRNAs, on the basic of correlation cutoff 0.99 and P-value<0.05. We searched lncRNAmRNA pairs whose distance of genomic locations was less than 10kb. In addition, we blatted the sequences of lncRNA and 3‘UTR of mRNAs to screen the sequence similarity lncRNA-mRNA pairs. We then got 33 lncRNA-mRNA pairs. The mRNAs of pairs were considered the target genes of lncRNAs. From the mRNAs, we found that TERC was likely a useful biomarker for the diagnosis of the non-small cell carcinoma. As the ENST00000363312 and sno-RNA_scaRNA_0_548 also had the similar function, we considered that they were likely useful biomarkers for the diagnosis of the non-small cell carcinoma. We concluded that lncRNAs differentially expressed in lung tumor tissues and normal tissues may exert a partial or key role in lung tumor development, and may provide potential targets for future treatment of lung squamous cell carcinoma.

Clinical Roles of the Aberrantly Expressed Lncrnas in Lung Squamous Cell Carcinoma: a Study Based on RNA-sequencing and Microarray Data Mining

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma

Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma

Genome-scale lncRNAs Expressions Pattern in Lung Squamous Carcinoma

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data

SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 Are Crucial Long Non-Coding RNAs Associated with the Prognosis of Lung Squamous Cell Carcinoma.

Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.

Characterization of Micrornas and Lncrnas in Early-Stage Squamous Cell Carcinoma Based on the Analysis of TCGA Datasets

Comprehensive Analysis of Aberrantly Expressed Profiles of Lncrnas and Mirnas with Associated Cerna Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Integrated Analysis of Competing Endogenous RNA Network Revealing Lncrnas As Potential Prognostic Biomarkers in Human Lung Squamous Cell Carcinoma

LncRNAs Are Altered in Lung Squamous Cell Carcinoma and Lung Adenocarcinoma.

Systematic Analysis Using a Bioinformatics Strategy Identifies SFTA1P and LINC00519 As Potential Prognostic Biomarkers for Lung Squamous Cell Carcinoma

Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma

Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma.

Diagnosis Value of Aberrantly Expressed Microrna Profiles in Lung Squamous Cell Carcinoma: a Study Based on the Cancer Genome Atlas

Using RNA Sequencing to Identify a Putative Lncrna-Associated Cerna Network in Laryngeal Squamous Cell Carcinoma

Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression

Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.

[LINC00668 is Highly Expressed in Lung Squamous Cell Carcinoma and Promotes Tumor Cell Migration and Invasion].

Prognostic value of CASC15 and LINC01600 as competitive endogenous RNAs in lung adenocarcinoma: An observational study